Clinical Trial Update: Cyclosporine Dose Adjustment According to Calcineurin Activity After Allogeneic Hematopoietic Stem-cell Transplantation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on adjusting cyclosporine dosing according to calcineurin activity after allogeneic hematopoietic stem cell transplantation to man…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• CYCLOSPORINE (cyclosporine)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Hematopoietic Stem Cell Transplantation, Graft Versus Host Disease | Phase 2 | Status: COMPLETED